Applications of glycosaminoglycans in the medical, veterinary, pharmaceutical, and cosmetic fields
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Springer International Publishing
2017
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 41501caa a22022457a 4500 | ||
|---|---|---|---|
| 001 | PAPER-17629 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204858.0 | ||
| 008 | 190410s2017 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-85035359020 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a Kovensky, J. | |
| 245 | 1 | 0 | |a Applications of glycosaminoglycans in the medical, veterinary, pharmaceutical, and cosmetic fields |
| 260 | |b Springer International Publishing |c 2017 | ||
| 270 | 1 | 0 | |m Uhrig, M.L.; Facultad de Ciencias Exactas y Naturales, Departamento de Química Orgánica, Universidad de Buenos Aires, Pabellón 2, Ciudad Universitaria, Argentina; email: mluhrig@qo.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Afratis, N.A., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A.D., Pavao, M.S., Karamanos, N.K., Glycosaminoglycans: key players in cancer cell biology and treatment (2012) FEBS J, 279, pp. 1177-1197 | ||
| 504 | |a Afratis, N.A., Karamanos, N.K., Piperigkou, Z., Vynios, D.H., Theocharis, A.D., The role of heparins and nano-heparins as therapeutic tool in breast cancer (2016) Glycoconj J | ||
| 504 | |a Ahmad, S., Ansari, A.A., Therapeutic roles of heparin anticoagulants in cancer and related disorders (2011) Med Chem, 7, pp. 504-517 | ||
| 504 | |a Aimi, T., Suzuki, K., Hoshino, T., Mizushima, T., Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein (2015) J Neurochem, 134, pp. 611-617 | ||
| 504 | |a Aquino, S.A., Park, P.W., Diverse functions of glycosaminoglycans in infectious diseases (2010) Prog Mol Biol Transl Sci, 93, pp. 373-394 | ||
| 504 | |a Aquino, S.A., Park, P.W., Glycosaminoglycans and infection (2016) Front Biosci (Landmark Ed), 21, pp. 1260-1277 | ||
| 504 | |a Arevalo, M.T., Simpson-Haidaris, P.J., Jin, X., Chen, H., Quinn, M.H., Compositions and methods for inhibition of or treatment of dengue virus infection (2011) PCT Int Appl WO 2011153458 | ||
| 504 | |a Axelsson, J., Xu, D., Kang, B.N., Nussbacher, J.K., Handel, T.M., Ley, K., Sriramarao, P., Esko, J.D., Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice (2012) Blood, 120, pp. 1742-1751 | ||
| 504 | |a Bachar, G., Cohen, K., Hod, R., Feinmesser, R., Mizrachi, A., Shpitzer, T., Katz, O., Peer, D., Hyaluronan-grafted particle clusters loaded with mitomycin C as selective nanovectors for primary head and neck cancers (2011) Biomaterials, 32, pp. 4840-4848 | ||
| 504 | |a Badylak, S.F., Biomaterial derived from vertebrate liver tissue (1997), US; Badylak, S.F., Demeter, R.J., Hiles, M., Voytik, S.L., Knapp, P.M., Jr., Fluidized intestinal submucosa and its use as an injectable tissue graft (1994), US; Badylak, S.F., Voytik, S.L., Brightman, A., Waninger, M., Urinary bladder submucosa derived tissue graft (1995), US; Badylak, S.F., Voytik-Harbin, S.L., Brightman, A.O., Tullius, R.S., Stomach submucosa derived tissue graft (1997), US; Barrowcliffe, T.J., History of heparin (2012) Handb Exp Pharmacol, 207, pp. 3-22 | ||
| 504 | |a Basappa, Rangappa, K.S., Sugahara, K., Roles of glycosaminoglycans and glycanmimetics in tumor progression and metastasis (2014) Glycoconj J, 31, pp. 461-467 | ||
| 504 | |a Beasley, K.L., Weiss, M., Weiss, R.A., Hyaluronic acid fillers: a comprehensive review (2009) Facial Plast Surg, 25, pp. 86-94 | ||
| 504 | |a Bedini, E., Parrilli, M., Synthetic and semi-synthetic chondroitin sulfate oligosaccharides, polysaccharides, and glycomimetics (2012) Carbohydr Res, 356, pp. 75-85 | ||
| 504 | |a Belting, M., Glycosaminoglycans in cancer treatment (2014) Thromb Res, 133, pp. S95-S101 | ||
| 504 | |a Benitez, A., Yates, T.J., Lopez, L.E., Cerwinka, W.H., Bakkar, A., Lokeshwar, V.B., Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells (2011) Cancer Res, 71, pp. 4085-4095 | ||
| 504 | |a Bernstein, E.F., Underhill, C.B., Hahn, P.J., Brown, D.B., Uitto, J., Chronic sun exposure alters both the content and distribution of dermal glycosaminoglycans (1996) Br J Dermatol, 135, pp. 255-262 | ||
| 504 | |a Boeriu, C.G., Springer, J., Kooy, F.K., van den Broek, L.A.M., Eggink, G., Production methods for hyaluronan (2013) Int J Carbohydr Chem, 2013, p. 14 | ||
| 504 | |a Bonafe, F., Govoni, M., Giordano, E., Caldarera, C., Guarnieri, C., Muscari, C., Hyaluronan and cardiac regeneration (2014) J Biomed Sci, 21 (100), p. 13 | ||
| 504 | |a Borsig, L., Vlodavsky, I., Ishai-Michaeli, R., Torri, G., Vismara, E., Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase (2011) Neoplasia, 13, pp. 445-452 | ||
| 504 | |a Bottegoni, C., Muzzarelli, R.A.A., Giovannini, F., Busilacchi, A., Gigante, A., Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis (2014) Carbohydr Polym, 109, pp. 126-138 | ||
| 504 | |a Brougham, C.M., Levingstone, T.J., Jockenhoevel, S., Flanagan, T.C., O'Brien, F.J., Incorporation of fibrin into a collagen-glycosaminoglycan matrix results in a scaffold with improved mechanical properties and enhanced capacity to resist cell-mediated contraction (2015) Acta Biomater, 26, pp. 205-214 | ||
| 504 | |a Cagno, V., Donalisio, M., Civra, A., Volante, M., Veccelli, E., Oreste, P., Rusnati, M., Lembo, D., Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures (2014) Antimicrob Agents Chemother, 58, pp. 4782-4794 | ||
| 504 | |a Campion, C., Pini, A.P.J., Gogoi, R.N., Gilthorpe, J., Sulfated oligosaccharides for use in treatment of neurodegenerative diseases (2012), PCT Int Appl WO 2012/160337; Capila, I., Linhardt, R.J., Heparin-protein interactions (2002) Angew Chem Int Ed Eng, 41, pp. 390-412 | ||
| 504 | |a Cayre, Y., Allouche, R., Produit pour lutter contre la prolifération des cellules cancéreuse (2017), Fr Demande FR 3039065; Chang, P.-H., Pharmaceutical formulation containing glycosaminoglycan (2014), PCT Int Appl WO 2014142938, PCT Int Appl WO 2014143085; Cheng, G., Cao, B., Zwitterionic polysaccharide polymers having antifouling, antimicrobial and optical transparency properties (2015), PCT Int Appl WO 2015057645 A1; Conrad, H.E., Heparin-binding proteins (1998) Academic, San Diego | ||
| 504 | |a Coombe, D.R., Kett, W.C., Heparan sulfate-protein interactions: therapeutic potential through structure-function insights (2005) Cell Mol Life Sci, 62, pp. 410-424 | ||
| 504 | |a Coppa, G.V., Facinelli, B., Magi, G., Marini, E., Zampini, L., Mantovani, V., Galeazzi, T., Gabrielli, O., Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells (2016) Pediatr Res, 79, pp. 603-607 | ||
| 504 | |a Cordo Russo, R.I., García, M.G., Alaniz, L., Blanco, G., Alvarez, E., Hajos, S.E., Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway (2008) Int J Cancer, 122, pp. 1012-1018 | ||
| 504 | |a Crepaldi, G., Fellin, R., Calabrò, A., Rossi, A., Ventura, A., Mannarino, E., Senin, U., Lalloni, L., Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan current therapeutic effects and perspectives for clinical use (1990) Atherosclerosis, 81, pp. 233-243 | ||
| 504 | |a Cruz, L., Meyers, C., Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types (2013) PLoS One, 8, p. e68379 | ||
| 504 | |a Da Costa Dias, B., Jovanovic, K., Gonsalves, D., Weiss, S.F.T., Structural and mechanistic commonalities of amyloid-β and the prion protein (2011) Prion, 5, pp. 126-137 | ||
| 504 | |a Davis, D.A.S., Parish, C.R., Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity (2013) Front Immunol, 4 (470), p. 7 | ||
| 504 | |a De Vita, D., Giordano, S., Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study (2012) Int Urogynecol J, 23, pp. 1707-1713 | ||
| 504 | |a DeAngelis, P.L., Lane, R.S., Heparosan/therapeutic prodrug complexes and methods of making and using same (2016), WO 2016/065309; DeAngelis, P.L., Liu, J., Linhardt, R.J., Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains (2013) Glycobiology, 23, pp. 764-777 | ||
| 504 | |a Della Valle, F., Romeo, A., Esters of hyaluronic acid (1989), US; Dicker, K.T., Gurski, L.A., Pradhan-Bhatt, S., Witt, R.L., Farach-Carson, M.C., Jia, X., Hyaluronan: a simple polysaccharide with diverse biological functions (2014) Acta Biomater, 10, pp. 1558-1570 | ||
| 504 | |a Eklund, E., Ekman-Ordeberg, G., Malmstrom, A., Treatment of cytokine mediated conditions (2013), Can Pat Appl CA 2779838; Esko, J.D., Special considerations for proteoglycans and glycosaminoglycans and their purification (2001) Curr Protoc Mol Biol, 17, pp. 17.2.1-17.2.9 | ||
| 504 | |a Fabricius, H.-A., Sulfated polysaccharides for use in the treatment of cancer (2015), PCT Int Appl WO 2015/059177; Finelli, I., Chiessi, E., Galesso, D., Renier, D., Paradossi, G., Gel-like structure of a hexadecyl derivative of hyaluronic acid for the treatment of osteoarthritis (2009) Macromol Biosci, 9, pp. 646-653 | ||
| 504 | |a Fitton, H., Gardiner, V., Anti-viral formulations (2011), PCT Int Appl WO 2011/100805; Flores Salgado, F., Benitez Jimenez, A.F., Costa Rierola, M., Flores Costa, R., Flores Costa, L., Partially depolymerized glycosaminoglycan silver and gold salts (2013), PCT Int Appl WO 2013/121001; Freudenberg, U., Zieris, A., Chwalek, K., Tsurkan, M.V., Maitz, M.F., Atallah, P., Levental, K.R., Werner, C., Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds (2015) J Control Release, 220, pp. 79-88 | ||
| 504 | |a Fu, L., Suflita, M., Linhardt, R.J., Bioengineered heparins and heparan sulfates (2016) Adv Drug Deliv Rev, 97, pp. 237-249 | ||
| 504 | |a Fukuda, T., Matsumoto, E., Miura, Y., Interaction between multimeric sulfated saccharides and Alzheimer amyloid β (1-42) (2015) Chem Lett, 44, pp. 1482-1484 | ||
| 504 | |a Funderburgh, J.L., Keratan sulfate: structure, biosynthesis, and function (2000) Glycobiology, 10, pp. 951-958 | ||
| 504 | |a Fux, L., Ilan, N., Sanderson, R.D., Vlodavsky, I., Heparanase: busy at the cell surface (2009) Trends Biochem Sci, 34, pp. 511-519 | ||
| 504 | |a Galus, A., Mallet, J.-M., Lembo, D., Cagno, V., Djabourov, M., Lortat-Jacob, H., Bouchemal, K., Hexagonal-shaped chondroitin sulfate self-assemblies have exalted anti-HSV-2 activity (2016) Carbohydr Polym, 136, pp. 113-120 | ||
| 504 | |a García, B., Merayo-Lloves, J., Martin, C., Alcalde, I., Quirós, L.M., Vazquez, F., Surface proteoglycans as mediators in bacterial pathogens infections (2016) Front Microbiol, 7 (220), p. 11 | ||
| 504 | |a Genco, T., Zemljič, L.F., Bračič, M., Stana-Kleinschek, K., Heinze, T., Physicochemical properties and bioactivity of a novel class of cellulosics: 6-deoxy-6-amino cellulose sulfate (2012) Macromol Chem Phys, 213, pp. 539-548 | ||
| 504 | |a Gilbert, T.W., Sellaro, T.L., Badylak, S.F., Decellularization of tissues and organs (2006) Biomaterials, 27, pp. 3675-3683 | ||
| 504 | |a Gomes, A.M., Stelling, M.P., Pavão, M.S.G., Heparan sulfate and heparanase as modulators of breast cancer progression (2013) BioMed Res Int, p. 11. , 852093 | ||
| 504 | |a Gomes, A.M., Kozlowski, E.O., Borsig, L., Teixeira, F.C.O.B., Vlodavsky, I., Pavão, M.S.G., Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus:effect on P-selectin, heparanase, metastasis and cellular recruitment (2015) Glycobiology, 25, pp. 386-393 | ||
| 504 | |a Gray, E., Hogwood, J., Mulloy, B., The anticoagulant and antithrombotic mechanisms of heparin (2012) Handb Exp Pharmacol, 207, pp. 43-61 | ||
| 504 | |a Grohmann, S., Hildebrand, G., Liefeith, K., Active substance-loaded biocompatible polyelectrolyte multilayers based on sulfated glycosaminoglycans, methods for producing the multilayers, and use of the multilayers (2014), PCT Int Appl WO 2014/147080; Ger Offen DE 102013204742; Harenberg, J., Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide (1998) Med Res Rev, 18, pp. 1-20 | ||
| 504 | |a Hendricks, G.L., Velazquez, L., Pham, S., Qaisar, N., Delaney, J.C., Viswanathan, K., Albers, L., Finberg, R.W., Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses (2015) Antivir Res, 116, pp. 34-44 | ||
| 504 | |a Herrero, L.J., Foo, S.-S., Sheng, K.-C., Chen, W., Forwood, M.R., Bucala, R., Mahalingam, S., Pentosan polysulfate: a novel glycosaminoglycan-like molecule for the effective treatment of alphavirus-induced cartilage destruction and inflammatory disease (2015) J Virol, 89, pp. 8063-8076 | ||
| 504 | |a Herrero-Mendez, A., Palomares, T., Castro, B., Herrero, J., Granado, M.H., Bejar, J.M., Alonso-Varona, A., HR007: a family of biomaterials based on glycosaminoglycans for tissue repair (2015) J Tissue Eng Regen Med | ||
| 504 | |a Hidari, K.I., Abe, T., Suzuki, T., Carbohydrate-related inhibitors of dengue virus entry (2013) Viruses, 5, pp. 605-618 | ||
| 504 | |a Hoshiba, T., Chen, G., Endo, C., Maruyama, H., Wakui, M., Nemoto, E., Kawazoe, N., Tanaka, M., Decellularized extracellular matrix as an in vitro model to study the comprehensive roles of the ECM in stem cell differentiation (2016) Stem Cells Int, p. 10 | ||
| 504 | |a Huang, Y., Yao, X., Zhang, R., Ouyang, L., Jiang, R., Liu, X., Song, C., Huang, W., Cationic conjugated polymer/fluoresceinamine-hyaluronan complex for sensitive fluorescence detection of CD44 and tumor-targeted cell imaging (2014) ACS Appl Mater Interfaces, 6, pp. 19144-19153 | ||
| 504 | |a Jia, X., Kiick, K.L., Hybrid multicomponent hydrogels for tissue engineering (2009) Macromol Biosci, 9, pp. 140-156 | ||
| 504 | |a Jinno-Oue, A., Tanaka, A., Shimizu, N., Mori, T., Sugiura, N., Kimata, K., Isomura, H., Hoshino, H., Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1 (2013) AIDS Res Hum Retrovir, 29, pp. 621-629 | ||
| 504 | |a Kallestrup, E., Jørgensen, S., Nordling, J., Hald, T., Treatment of interstitial cystitis with Cystistat®, a hyaluronic acid product (2005) Scand J Urol Nephrol, 39, pp. 143-147 | ||
| 504 | |a Kavasi, R.M., Berdiaki, A., Spyridaki, I., Corsini, E., Tsatsakis, A., Tzanakakis, G., Nikitovic, D., HA metabolism in skin homeostasis and inflammatory disease (2017) Food Chem Toxicol, 101, pp. 128-138 | ||
| 504 | |a Keane, T.J., Swinehart, I.T., Badylak, S.F., Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance (2015) Methods, 84, pp. 25-34 | ||
| 504 | |a Khaderi, K., Compositions and methods for treating injuries to the visual system of a human. (2014); Khanlari, A., Detamore, M.S., Gehrke, S.H., Increasing cross-linking efficiency of methacrylated chondroitin sulfate hydrogels by copolymerization with oligo(ethylene glycol) diacrylates (2013) Macromolecules, 46, pp. 9609-9617 | ||
| 504 | |a Khanlari, A., Suekama, T.C., Gehrke, S.H., Structurally versatile glycosaminoglycan hydrogels for biomedical applications (2015) Macromol Symp, 358, pp. 67-77 | ||
| 504 | |a Khanlari, A., Suekama, T.C., Detamore, M.S., Gehrke, S.H., Structurally diverse and readily tunable photocrosslinked chondroitin sulfate based copolymers (2015) J Polym Sci Part B Polym Phys, 53, pp. 1070-1079 | ||
| 504 | |a Khanlari, A., Schulteis, J.E., Suekama, T.C., Detamore, M.S., Gehrke, S.H., Designing crosslinked hyaluronic acid hydrogels with tunable mechanical properties for biomedical applications (2015) J Appl Polym Sci, 132 | ||
| 504 | |a Kim, E., Okumura, M., Sawa, H., Miyazaki, T., Fujikura, D., Yamada, S., Sugahara, K., Kimura, T., Paradoxical effects of chondroitin sulfate-E on Japanese encephalitis viral infection (2011) Biochem Biophys Res Commun, 409, pp. 717-722 | ||
| 504 | |a Kim, S.-H., Turnbull, J., Guimond, S.J., Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor (2011) Endocrinology, 209, pp. 139-151 | ||
| 504 | |a Kirn-Safran, C.B., D'Souza, S.S., Carson, D.D., Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation (2008) Semin Cell Dev Biol, 19, pp. 187-193 | ||
| 504 | |a Kobayashi, F., Yamada, S., Taguwa, S., Kataoka, C., Naito, S., Hama, Y., Tani, H., Sugahara, K., Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus (2012) Glycoconj J, 29, pp. 211-220 | ||
| 504 | |a Kozlowski, E.O., Pavao, M.S.G., Effect of sulfated glycosaminoglycans on tumor invasion and metastasis (2011) Front Biosci Sch Ed, pp. 1541-1551 | ||
| 504 | |a Kozlowski, E.O., Pavao, M.S.G., Borsig, L., Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin (2011) J Thromb Haemost, 9, pp. 1807-1815 | ||
| 504 | |a Krichen, F., Volpi, N., Sila, A., Maccari, F., Mantovani, V., Galeotti, F., Ellouz-Chaabouni, S., Bougatef, A., Purification, structural characterization and antiproliferative properties of chondroitin sulfate/dermatan sulfate from tunisian fish skins (2017) Int J Biol Macromol, 95, pp. 32-39 | ||
| 504 | |a Kroma, A., Feliczak-Guzik, A., Nowak, I., The use of glycosaminoglycans in cosmetic products (2012) Chemik, 66, pp. 136-139 | ||
| 504 | |a Kwok, J.C.F., Warren, P., Fawcett, J.W., Chondroitin sulfate: a key molecule in the brain matrix (2012) Int J Biochem Cell Biol, 44, pp. 582-586 | ||
| 504 | |a Ladet, S., Multilayer implants for delivery of therapeutic agents (2013), PCT Int Appl WO 2013046057; Lee, E.C., Davis-Poynter, N., Nguyen, C.T.H., Peters, A.A., Monteith, G.R., Strounina, E., Popat, A., Ross, B.P., GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses (2016) Nanoscale, 8, pp. 16192-16196 | ||
| 504 | |a Lee-Sayer, S.S.M., Dong, Y., Arif, A.A., Olsson, M., Brown, K.L., Johnson, P., The where, when, how, and why of hyaluronan binding by immune cells (2015) Front Immunol, 6, p. 150 | ||
| 504 | |a Ley, K., Cerrito, M., Arfors, K.E., Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules (1991) Am J Phys, 260, pp. 1667-1673 | ||
| 504 | |a Li, Y., Liu, Y., Xia, W., Lei, D., Voorhees, J.J., Fisher, G.J., Age-dependent alterations of decorin glycosaminoglycans in human skin (2013) Sci Rep, 3 (2422), p. 8 | ||
| 504 | |a Lian, W., Wu, M., Huang, N., Gao, N., Xiao, C., Li, Z., Zhang, Z., Zhao, J., Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope (2013) Biochim Biophys Acta, 1830, pp. 4681-4691 | ||
| 504 | |a Liang, Y., Kiick, K.L., Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications (2014) Acta Biomater, 10, pp. 1588-1600 | ||
| 504 | |a Liaw, P.C., Becker, D.L., Stafford, A.R., Fredenburgh, J.C., Weitz, J.I., Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin (2001) J Biol Chem, 276, pp. 20959-20965 | ||
| 504 | |a Lin, H.-Y., Compound of glycosaminoglycan, preparation method and use thereof (2015), PCT Int Appl WO 2015/028172 A1; US Appl Publ US; Liu, L., Liu, Y., Li, J., Du, G., Chen, J., Microbial production of hyaluronic acid: current state, challenges, and perspectives (2011) Microb Cell Factories, 10, pp. 99-108 | ||
| 504 | |a Liu, C.-C., Zhao, N., Kanekiyo, T., Yamaguchi, Y., Cirrito, J.R., Holtzman, D.M., Bu, G., Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease (2016) Sci Transl Med, 8, p. 332ra44 | ||
| 504 | |a Lompardía, S.L., Díaz, M., Papademetrio, D.L., Mascaró, M., Pibuel, M., Álvarez, E., Hajos, S.E., Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib (2016) Glycobiology, 26, pp. 343-352 | ||
| 504 | |a Lundin, A., Bergström, T., Andrighetti-Fröhner, C.R., Bendrioua, L., Ferro, V., Trybala, E., Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate (2012) Antivir Res, 93, pp. 101-109 | ||
| 504 | |a Manveen, K., Sethi, M.K., Zaia, J., Extracellular matrix proteomics in schizophrenia and Alzheimer's disease (2017) Anal Bioanal Chem, 409, pp. 379-394 | ||
| 504 | |a Marchi, E., Tamagnone, G., Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it (1994), US; Martín, R., Martín, C., Escobedo, S., Suárez, J.E., Quirós, L.M., Surface glycosaminoglycans mediate adherence between HeLa cells and lactobacillus salivarius Lv72 (2013) BMC Microbiol, 13 (210), p. 11 | ||
| 504 | |a Martinez, P., Vergoten, G., Colomb, F., Bobowski, M., Steenackers, A., Carpentier, M., Allain, F., Julien, S., Over-sulfated glycosaminoglycans are alternative selectin ligands: insights into molecular interactions and possible role in breast cancer metastasis (2013) Clin Exp Metastasis, 30, pp. 919-931 | ||
| 504 | |a Matheny, R.G., Compositions and methods for preventing cardiac arrhythmia (2015), US; Mathieu, C., Dhondt, K.P., Chalons, M., Mely, S., Raoul, H., Negre, D., Cosset, F.-L., Horvat, B., Heparan sulfate-dependent enhancement of henipavirus infection (2015) MBio, 6, pp. 1-10 | ||
| 504 | |a Memi, E., Karakiulakis, G., Goma, F., Papakonstantinou, E., The functional role of glycosaminoglycans in the pathophysiology of the thyroid gland and their putative role as prognostic, diagnostic and therapeutic agents in thyroid pathologies (2012) Rev Clin Pharmacol Pharmacokinet Int Ed, 26, pp. 61-86 | ||
| 504 | |a Mikami, T., Kitagawa, H., Biosynthesis and function of chondroitin sulfate (2013) Biochim Biophys Acta Gen Subj, 1830, pp. 4719-4733 | ||
| 504 | |a Misra, S., Hascall, V.C., Markwald, R.R., Ghatak, S., Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer (2015) Front Immunol, 6 (201), p. 31 | ||
| 504 | |a Mizumoto, S., Sugahara, Glycosaminoglycans are functional ligands for receptor for advanced glycation end-products in tumors (2013) FEBS J, 280, pp. 2462-2470 | ||
| 504 | |a Mizumoto, S., Takahashi, J., Sugahara, K., Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells (2012) J Biol Chem, 287, pp. 18985-18994 | ||
| 504 | |a Monfort, J., Pelletier, J.-P., Garcia-Giralt, N., Martel-Pelletier, J., Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues (2008) Ann Rheum Dis, 67, pp. 735-740 | ||
| 504 | |a Mousa, S.A., Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis (2015), US Appl Publ US; Mousa, S.A., Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection (2016), USAppl Publ; Murphy, C.M., Duffy, G.P., Schindeler, A., O'Brien, F.J., Effect of collagen-glycosaminoglycan scaffold pore size on matrix mineralization and cellular behavior in different cell types (2016) J Biomed Mater Res Part A, 104, pp. 291-304 | ||
| 504 | |a Nakano, T., Betti, M., Pietrasik, Z., Extraction, isolation and analysis of chondroitin sulfate glycosaminoglycans (2010) Recent Pat Food Nutr Agric, 2, pp. 61-74 | ||
| 504 | |a Nickel, J.C., Egerdie, R.B., Steinhoff, G., Palmer, B., Hanno, P., A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome (2010) Urology, 76, pp. 804-809 | ||
| 504 | |a Nikitovic, D., Chatzinikolaou, G., Tsiaoussis, J., Tsatsakis, A., Karamanos, N.K., Tzanakakis, G.N., Insights into targeting colon cancer cell fate at the level of proteoglycans/glycosaminoglycans (2012) Curr Med Chem, 19, pp. 4247-4258 | ||
| 504 | |a Nishimura, Y., Shudo, H., Seto, H., Hoshino, Y., Miura, Y., Syntheses of sulfated glycopolymers and analyses of their BACE-1 inhibitory activity (2013) Bioorg Med Chem Lett, 23, pp. 6390-6395 | ||
| 504 | |a Nugent, M.A., Heparin sequencing brings structure to the function of complex oligosaccharides (2000) Proc Natl Acad Sci U S A, 97, pp. 10301-10303 | ||
| 504 | |a O'Hearn, A., Wang, M., Cheng, H., Lear-Rooney, C.M., Koning, K., Rumschlag-Booms, E., Varhegyi, E., Rong, L., Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry (2015) J Virol, 89, pp. 5441-5449 | ||
| 504 | |a Papakonstantinou, E., Roth, M., Karakiulakis, G., Hyaluronic acid: a key molecule in skin aging (2012) Dermato-Endocrinol, 4, pp. 253-258 | ||
| 504 | |a Papy-Garcia, D., Christophe, M., Huynh, M.B., Sineriz, F., Sissoeff, L., Sepulveda-Diaz, J.E., Raisman-Vozari, R., Glycosaminoglycans, protein aggregation and neurodegeneration (2011) Curr Protein Pept Sci, 12, pp. 258-268 | ||
| 504 | |a Papy-Garcia, D., Huynh, M.B., Soussi-Yanicostas, N., Vozari, R., Sineriz, F., Yanicostas, C., Method of diagnosis, prognosis, or treatment of neurodegenerative diseases (2013) PCT Int Appl WO 2013/053954. | ||
| 504 | |a Paul, T.J., Kelly, H., Zuchniarz, J., Ahmed, T., Prabhakar, R., Design of heparin oligosaccharide based molecules for inhibition of Alzheimer amyloid beta (Aβ40) aggregation (2016) Can J Chem, 94, pp. 1090-1098 | ||
| 504 | |a Peer, D., Liposomal formulations for delivery of nucleic acids (2015), Int Appl WO 2015/198326; Persson, A., Tykesson, E., Westergren-Thorsson, G., Malmström, A., Ellervik, U., Mani, K., Xyloside-primed chondroitin sulfate/dermatan sulfate from breast carcinoma cells with a defined disaccharide composition has cytotoxic effects in vitro (2016) J Biol Chem, 291, pp. 14871-14882 | ||
| 504 | |a Petrey, A.C., de la Motte, C.A., Hyaluronan, a crucial regulator of inflammation (2014) Front Immunol, 5, p. 101 | ||
| 504 | |a Pisano, C., Vlodavsky, I., Ilan, N., Zunino, F., The potential of heparanase as a therapeutic target in cancer (2014) Biochem Pharmacol, 89, pp. 12-19 | ||
| 504 | |a Pomin, V.H., A dilemma in the glycosaminoglycan-based therapy: synthetic or naturally unique molecules? (2015) Med Res Rev, 35, pp. 1195-1219 | ||
| 504 | |a Pomin, V.H., Sulfated glycans in inflammation (2015) Eur J Med Chem, 92, pp. 353-369 | ||
| 504 | |a Pomin, V.H., Mulloy, B., Current structural biology of the heparin interactome (2015) Curr Opin Struct Biol, 34, pp. 17-25 | ||
| 504 | |a Prestwich, G.D., Kennedy, T.P., Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers (2011), PCT Int Appl WO 2011/094149; Prestwich, G.D., Oottamasathein, S., Kennedy, T., Applications of partially and fully sulfated hyaluronan (2011), PCT Int Appl WO 2011/156445; Prestwich, G.D., Oottamasathien, S., Kennedy, T.P., Applications of partially and fully sulfated hyaluronan (2013), USAppl; Puperi, D.S., O'Connell, R.W., Punske, Z.E., Wu, Y., West, J.L., Grande-Allen, K.J., Hyaluronan hydrogels for a biomimetic spongiosa layer of tissue engineered heart valve scaffolds (2016) Biomacromolecules, 17, pp. 1766-1775 | ||
| 504 | |a Pye, D.A., Ogundipe, O.D., Pharmaceutical extracts and uses thereof (2016), PCT Int Appl WO 2016/067008; Qian, W., Tao, L., Wang, Y., Zhang, F., Li, M., Huang, S., Wang, A., Lu, Y., Downregulation of integrins in cancer cells and anti-platelet properties are involved in holothurian glycosaminoglycan-mediated disruption of the interaction of cancer cells and platelets in hematogenous metastasis (2015) J Vasc Res, 52, pp. 197-209 | ||
| 504 | |a Radhakrishnan, K., Tripathy, J., Datey, A., Chakravortty, D., Raichur, A.M., Mesoporous silica-chondroitin sulphate hybrid nanoparticles for targeted and bio-responsive drug delivery (2015) New J Chem, 39, pp. 1754-1760 | ||
| 504 | |a Rankin, K.S., Frankel, D., Hyaluronan in cancer - from the naked mole rat to nanoparticle therapy (2016) Soft Matter, 12, pp. 3841-3848 | ||
| 504 | |a Rawat, M., Hsieh-Wilson, L., Glycosaminoglycan mimetics (2014), US; Reinmueller, J., Dirting, K., Antiinfective composition (2012), PCT Int Appl WO 2012/168462; Ger Offen DE 102011077393; Ren, X., Weisgerber, D.W., Bischoff, D., Lewis, M.S., Reid, R.R., He, T.-C., Yamaguchi, D.T., Lee, J.C., Nanoparticulate mineralized collagen scaffolds and BMP-9 induce a long-term bone cartilage construct in human mesenchymal stem cells (2016) Adv Healthc Mater, 5, pp. 1821-1830 | ||
| 504 | |a Rilla, K., Tiihonen, R., Kultti, A., Tammi, M., Tammi, R., Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions (2008) J Histochem Cytochem, 56, pp. 901-910 | ||
| 504 | |a Ritchie, J.P., Ramani, V.C., Ren, Y., Naggi, A., Torri, G., Casu, B., Penco, S., Yang, Y., SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis (2011) Clin Cancer Res, 17, pp. 1382-1393 | ||
| 504 | |a Ronca, F., Palmieri, L., Panicucci, P., Ronca, G., Anti-inflammatory activity of chondroitin sulfate (1998) Osteoarthr Cartil, 6, pp. 14-21 | ||
| 504 | |a Said, J.S., Trybala, E., Görander, S., Ekblad, M., Liljeqvist, J.-A., Jennische, E., Lange, S., Bergström, T., The cholestanol-conjugated sulfated oligosaccharide PG545 disrupts the lipid envelope of herpes simplex virus particles (2016) Antimicrob Agents Chemother, 60, pp. 1049-1057 | ||
| 504 | |a Sakiyama-Elbert, S.E., Incorporation of heparin into biomaterials (2014) Acta Biomater, 10, pp. 1581-1587 | ||
| 504 | |a Salbach, J., Rachner, T.D., Rauner, M., Hempel, U., Anderegg, U., Franz, S., Simon, J.-C., Hofbauer, L.C., Regenerative potential of glycosaminoglycans for skin and bone (2012) J Mol Med, 90, pp. 625-635 | ||
| 504 | |a Savage, J.R., Pulsipher, A., Rao, N.V., Kennedy, T.P., Prestwich, G.D., Ryan, M.E., Lee, W.Y., A modified glycosaminoglycan, GM-0111, inhibits molecular signaling involved in periodontitis (2016) PLoS One, 11 | ||
| 504 | |a Sayari, N., Balti, R., Ben Mansour, M., Ben Amor, I., Graiet, I., Gargouri, J., Bougatef, A., Anticoagulant properties and cytotoxic effect against HCT116 human colon cell line of sulfated glycosaminoglycans isolated from the Norway lobster (Nephrops norvegicus) shell (2016) Biomed Pharmacother, 80, pp. 322-330 | ||
| 504 | |a Schaefer, L., Schaefer, R.M., Proteoglycans: from structural compounds to signaling molecules (2010) Cell Tissue Res, 339, pp. 237-246 | ||
| 504 | |a Schnabelrauch, M., Scharnweber, D., Schiller, J., Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues (2013) J Curr Med Chem, 20, pp. 2501-2523 | ||
| 504 | |a Schwoerer, R., Zubkova, O.V., Turnbull, J.E., Tyler, P.C., Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease (2013) Chem Eur J, 19, pp. 6817-6823 | ||
| 504 | |a Scott, I.R., Skin treatment composition (1988), EP 0295092 B1; Seki, Y., Mizukura, M., Ichimiya, T., Suda, Y., Nishihara, S., Masuda, M., Takase-Yoden, S., O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin (2012) Virology, 424, pp. 56-66 | ||
| 504 | |a Silva, L.A., Khomandiak, S., Ashbrook, A.W., Weller, R., Heise, M.T., Morrison, T.E., Dermody, T.S., A single-amino-acid polymorphism in chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization (2014) J Virol, 88, pp. 2385-2397 | ||
| 504 | |a Simionescu, D., Mercuri, J.J., Shape-memory sponge hydrogel biomaterial (2016), US; Spero, M., Weiss, M.S., Kopp, J.B., Methods using glycosaminoglycans for the treatment of kidney disease (2005), PCT Int Appl WO 2006039709 A1; Staples, G.O., Zaia, J., Mass spectrometry in carbohydrate sequencing and binding analysis (2011) Carbohydrate recognition: biological problems, pp. 257-300. , Wang B, Boons G-J (eds), methods, and applications. Wiley, Hoboken | ||
| 504 | |a Stern, R., Maibach, H.I., Hyaluronan in skin: aspects of aging and its pharmacologic modulation (2008) Clin Dermatol, 26, pp. 106-122 | ||
| 504 | |a Stewart, K.L., Hughes, E., Yates, E.A., Akien, G.R., Huang, T.-Y., Lima, M.A., Rudd, T.R., Middleton, D.A., Atomic details of the interactions of glycosaminoglycans with amyloid β fibrils (2016) J Am Chem Soc, 138, pp. 8328-8331 | ||
| 504 | |a Ströh, L.J., Stehle, T., Glycan engagement by viruses: receptor switches and specificity (2014) Ann Rev Virol, 1, pp. 285-306 | ||
| 504 | |a Tangso, K.J., da Cunha, P.H.C.D., Spicer, P., Li, J., Boyd, B.J., Antimicrobial activity from colistin-heparin lamellar-phase complexes for the coating of biomedical devices (2016) ACS Appl Mater Interfaces, 8, pp. 31321-31329 | ||
| 504 | |a Theocharis, A.D., Skandalis, S.S., Gialeli, C., Karamanos, N.K., Extracellular matrix structure (2016) Adv Drug Deliv Rev, 97, pp. 4-27 | ||
| 504 | |a Turley, E., Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications (2010), CA 2703532 A1; PCT Int Appl WO 2011/140630 A1; Tyler, P.C., Guimond, S.E., Turnbull, J.E., Zubkova, O.V., Single-entity heparan sulfate glycomimetic clusters for therapeutic applications (2015) Angew Chem Int Ed, 54, pp. 2718-2723 | ||
| 504 | |a Verges Milano, J., Garcia Garcia, A., Ruhi Roura, R., Montell Bonaventura, E., Garcia Lopez, M., Alaez Verson, C.R., Escaich Ferrer, J., Negredo Madrigal, P., Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases (2011), PCT Int. Appl. WO 2011/080203; Vistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., Aldini, G., Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation (2013) Free Radic Res, 47, pp. 3-27 | ||
| 504 | |a Volpi, N., Schiller, J., Stern, R., Soltes, L., Role, metabolism, chemical modifications and applications of hyaluronan (2009) Curr Med Chem, 16, pp. 1718-1745 | ||
| 504 | |a Von Recum, H.A., Hijaz, A., Glycosaminoglycans for chemokine drug delivery (2014), U.S. Pat. Appl.Publ. US 20140364360; Vuillermoz, B., Wegrowski, Y., Contet-Audonneau, J.-L., Danoux, L., Pauly, G., Maquart, F.-X., Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts (2005) Mol Cell Biochem, 277, pp. 63-72 | ||
| 504 | |a Wang, P., Ding, K., Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease (2014) Protein Pept Lett, 21, pp. 1048-1056 | ||
| 504 | |a Weigel, P.H., Fuller, G.M., LeBoeuf, R.D., A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing (1986) J Theor Biol, 119, pp. 219-234 | ||
| 504 | |a Wu, R.L., Huang, L., Zhao, H.-C., Geng, X.-P., Hyaluronic acid in digestive cancers (2017) J Cancer Res Clin Oncol, 143, pp. 1-16 | ||
| 504 | |a Xiao, L., Tong, Z., Chen, Y., Pochan, D.J., Sabanayagam, C.R., Jia, X., Hyaluronic acid-based hydrogels containing covalently integrated drug depots: implication for controlling inflammation in mechanically stressed tissues (2013) Biomacromolecules, 14, pp. 3808-3819 | ||
| 504 | |a Xu, D., Olson, J., Cole, J.N., van Wijk, X.M., Brinkmann, V., Zychlinsky, A., Nizet, V., Chang, Y.-C., Heparan sulfate modulates neutrophil and endothelial function in antibacterial innate immunity (2015) Infect Immun, 83, pp. 3648-3656 | ||
| 504 | |a Yang, R.-M., Fu, C.-P., Li, N.-N., Wang, L., Xu, X.-D., Yang, D.-Y., Fang, J.-Z., Zhang, L.-M., Glycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinoma (2014) Mater Sci Eng C Mater Biol Appl, 45, pp. 556-563 | ||
| 504 | |a Yang, X., Du, H., Liu, J., Zhai, G., Advanced nanocarriers based on heparin and its derivatives for cancer management (2015) Biomacromolecules, 16, pp. 423-436 | ||
| 504 | |a Yip, G.W., Smollich, M., Götte, M., Therapeutic value of glycosaminoglycans in cancer (2006) Mol Cancer Ther, 5, pp. 2139-2148 | ||
| 504 | |a Yue, Z., Wang, A., Zhu, Z., Tao, L., Li, Y., Zhou, L., Chen, W., Lu, Y., Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells (2015) Mol Cell Biochem, 410, pp. 143-154 | ||
| 504 | |a Yuk, S.H., Oh, K.S., Cho, S.H., Lee, B.S., Kim, S.Y., Kwak, B.K., Kim, K., Kwon, I.C., Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging (2011) Biomacromolecules, 12, pp. 2335-2343 | ||
| 504 | |a Zhang, Q., Li, J., Liu, C., Song, C., Li, P., Yin, F., Xiao, Y., Wang, F., Protective effects of low molecular weight chondroitin sulfate on amyloid beta (Aβ)-induced damage in vitro and in vivo (2015) Neuroscience, 305, pp. 169-182 | ||
| 504 | |a Zhang, R.R., Strebe, J.K., Kuo, J.S., Heparan sulfates promote amyloid pathology in Alzheimer disease (2016) Neurosurgery, 79, pp. N12-N13 | ||
| 504 | |a Zhang, X., Zhao, X., Lang, Y., Li, Q., Liu, X., Cai, C., Hao, J., Yu, G., Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer's β-secretase (2016) Carbohydr Polym, 151, pp. 51-59 | ||
| 504 | |a Zhao, W., McCallum, S.A., Xiao, Z., Zhang, F., Linhardt, R.J., Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides (2012) Biosci Rep, 32, pp. 71-81 | ||
| 504 | |a Zheng, S., Jin, Z., Han, J., Cho, S., Nguyen, V.D., Young Ko, S., Park, J.-O., Park, S., Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake (2016) Colloids Surf B: Biointerfaces, 143, pp. 27-36 | ||
| 504 | |a Zhong, W.P., Chin, H.G., Lee, E.J., Guo, S., Yip, G.W., Lam, Y., Divergent synthesis of chondroitin sulfate disaccharides and identification of sulfate motifs that inhibit triple negative breast cancer (2015) Sci Rep, 5, p. 8. , 14355 | ||
| 504 | |a Zhou, X., Jin, L., The structure-activity relationship of glycosaminoglycans and their analogues with β-amyloid peptide (2016) Protein Pept Lett, 23, pp. 358-364 | ||
| 504 | |a Zhou, H., Roy, S., Cochran, E., Zouaoui, R., Chu, C.L., Duffner, J., Zhao, G., Kishimoto, T.K., M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis (2011) PLoS One, 6, p. e21106 | ||
| 504 | |a Zhu, M., Feng, Q., Sun, Y., Li, G., Bian, L., Effect of cartilaginous matrix components on the chondrogenesis and hypertrophy of mesenchymal stem cells in hyaluronic acid hydrogels (2016) J Biomed Mater Res Part B Appl Biomater | ||
| 504 | |a Zieris, A., Dockhorn, R., Röhrich, A., Zimmermann, R., Müller, M., Welzel, P.B., Tsurkan, M.V., Werner, C., Biohybrid networks of selectively desulfated glycosaminoglycans for tunable growth factor delivery (2014) Biomacromolecules, 55, pp. 4439-4446 | ||
| 504 | |a Zimmer, R., Courty, J., Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans (2012), PCT Int Appl WO 2012/045750 | ||
| 593 | |a Laboratoire de Glycochimie, Des Antimicrobiens et des Agroressources (LG2A) CNRS UMR 7378, Institut de Chimie de Picardie CNRS FR 3085, Université de Picardie Jules Verne, 33 rue Saint Leu, Amiens Cedex, 80039, France | ||
| 593 | |a Facultad de Ciencias Exactas y Naturales, Departamento de Química Orgánica, Universidad de Buenos Aires, Pabellón 2, Ciudad Universitaria, Buenos Aires, C1428EHA, Argentina | ||
| 593 | |a Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-UBA, Centro de Investigación en Hidratos de Carbono (CIHIDECAR), Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a GLYCOSAMINOGLYCANS |
| 700 | 1 | |a Grand, E. | |
| 700 | 1 | |a Uhrig, M.L. | |
| 773 | 0 | |d Springer International Publishing, 2017 |h pp. 135-164 |p Ind. Appl. of Renew. Biomass Prod.: Past, Present and Future |z 9783319612881 |z 9783319612874 |t Industrial Applications of Renewable Biomass Products: Past, Present and Future | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035359020&doi=10.1007%2f978-3-319-61288-1_5&partnerID=40&md5=f60af6e93e2d3fb75815d93938bd4285 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-61288-1_5 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_97833196_v_n_p135_Kovensky |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_97833196_v_n_p135_Kovensky |y Registro en la Biblioteca Digital |
| 961 | |a paper_97833196_v_n_p135_Kovensky |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/bookPart |a info:ar-repo/semantics/parte de libro |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 78582 | ||